Analysis of SARS-CoV-2 Emergent Variants Following AZD7442 (Tixagevimab/Cilgavimab) for Early Outpatient Treatment of COVID-19 (TACKLE Trial)

被引：0

作者：

Gustavo H. Kijak

Bahar Ahani

Douglas Arbetter

Fernando Chuecos

Vancheswaran Gopalakrishnan

Jagadish Beloor

Tyler Brady

Amy Nguyen

Tiffany L. Roe

Nicolette Schuko

Tianhui Zhang

F. D. Richard Hobbs

Francisco Padilla

Elizabeth J. Kelly

Hugh Montgomery

Katie Streicher

机构：

[1] BioPharmaceuticals R&D,Translational Medicine, Vaccines & Immune Therapies

[2] AstraZeneca,Formerly Data Sciences and Quantitative Biology

[3] Bioinformatics,Nuffield Department of Primary Care Health Sciences

[4] Vaccines & Immune Therapies,Formerly Translational Medicine, Vaccines & Immune Therapies

[5] BioPharmaceuticals R&D,Department of Medicine

[6] AstraZeneca,undefined

[7] Biometrics,undefined

[8] Vaccines & Immune Therapies,undefined

[9] BioPharmaceuticals R&D,undefined

[10] AstraZeneca,undefined

[11] Biometrics,undefined

[12] Vaccines & Immune Therapies,undefined

[13] BioPharmaceuticals R&D,undefined

[14] AstraZeneca,undefined

[15] BioPharmaceuticals R&D,undefined

[16] AstraZeneca,undefined

[17] University of Oxford,undefined

[18] Centro de Investigación en Cardiología y Metabolismo,undefined

[19] BioPharmaceuticals R&D,undefined

[20] AstraZeneca,undefined

[21] University College London,undefined

来源：

Infectious Diseases and Therapy | 2023年 / 12卷

关键词：

AZD7442; Cilgavimab; COVID-19; Tixagevimab; Treatment-emergent viral variants;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：2691 / 2707

页数：16

共 50 条

[31] Pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) prevents severe SARS-CoV-2 infection in recipients of allogeneic hematopoietic stem cell transplantation during the Omicron wave: a multicentric retrospective study of SFGM-TC
Ludovic Jondreville
Maud D’Aveni
Hélène Labussière-Wallet
Amandine Le Bourgeois
Alban Villate
Ana Berceanu
Silvia-Maria Bezsera
Anne Thiebaut
Marion Boissard-Simonet
Marlène Legrand
Jérôme Cornillon
Marie-Thérèse Rubio
Patrice Chevallier
Stéphanie Nguyen
Journal of Hematology & Oncology, 15
[32] Role of COVID-19 Vaccines in SARS-CoV-2 Variants
Zhou, Zhou
Zhu, Yimiao
Chu, Ming
FRONTIERS IN IMMUNOLOGY, 2022, 13
[33] SARS-CoV-2 variants and ending the COVID-19 pandemic
Fontanet, Arnaud
Autran, Brigitte
Lina, Bruno
Kieny, Marie Paule
Karim, Salim S. Abdool
Sridhar, Devi
LANCET, 2021, 397 (10278): : 952 - 954
[34] Monoclonal Antibodies for Early Treatment of COVID-19 in a World of Evolving SARS-CoV-2 Mutations and Variants
Pogue, Jason M.
Lauring, Adam S.
Gandhi, Tejal N.
Marshall, Vincent D.
Eschenauer, Gregory A.
Nagel, Jerod L.
Baang, Ji Hoon
Zhou, Shiwei
Valesano, Andrew L.
Petty, Lindsay A.
OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (07):
[35] Pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) prevents severe SARS-CoV-2 infection in recipients of allogeneic hematopoietic stem cell transplantation during the Omicron wave: a multicentric retrospective study of SFGM-TC
Jondreville, Ludovic
D'Aveni, Maud
Labussiere-Wallet, Helene
Le Bourgeois, Amandine
Villate, Alban
Berceanu, Ana
Bezsera, Silvia-Maria
Thiebaut, Anne
Boissard-Simonet, Marion
Legrand, Marlene
Cornillon, Jerome
Rubio, Marie-Therese
Chevallier, Patrice
Nguyen, Stephanie
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
[36] Risk of SARS-CoV-2 infection and severe COVID-19 in hematological patients who received or not pre-exposure prophylaxis with tixagevimab/cilgavimab: a target trial emulation
Falcone, Marco
Tiseo, Giusy
Marchetti, Gabriele
Kalo, Jona
Galfo, Valentina
Occhineri, Sara
Almerigogna, Francesco
Matucci, Tommaso
Riccardi, Niccolo
Suardi, Lorenzo Roberto
Rina, Ines
Sijoni, Ledja
Caparello, Maria Costanza
Cassano, Raffaella Cassano
Del Giudice, Maria Livia
Franciosa, Marinunzia
Facella, Flaminia
Tancredi, Gaspare
Fazzi, Rita
Galimberti, Sara
LEUKEMIA & LYMPHOMA, 2024, 65 (10) : 1474 - 1481
[37] Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial
Montgomery, Hugh
Hobbs, F. D. Richard
Padilla, Francisco
Arbetter, Douglas
Templeton, Alison
Seegobin, Seth
Kim, Kenneth
Campos, Jesus Abraham Simon
Arends, Rosalinda H.
Brodek, Bryan H.
Brooks, Dennis
Garbes, Pedro
Jimenez, Julieta
Koh, Gavin C. K. W.
Padilla, Kelly W.
Streicher, Katie
Viani, Rolando M.
Alagappan, Vijay
Pangalos, Menelas N.
Esser, Mark T.
LANCET RESPIRATORY MEDICINE, 2022, 10 (10): : 985 - 996
[38] Analysis of SARS-CoV-2 Cases, COVID-19 Outcomes and Vaccinations, during the Different SARS-CoV-2 Variants in Greece
Malli, Foteini
Lampropoulos, Ioannis C.
Perlepe, Garifallia
Papagiannis, Dimitrios
Gourgoulianis, Konstantinos I.
VACCINES, 2023, 11 (01)
[39] Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab
Gupta, Anil
Gonzalez-Rojas, Yaneicy
Juarez, Erick
Casal, Manuel Crespo
Moya, Jaynier
Falci, Diego R.
Sarkis, Elias
Solis, Joel
Zheng, Hanzhe
Scott, Nicola
Cathcart, Andrea L.
Hebner, Christy M.
Sager, Jennifer
Mogalian, Erik
Tipple, Craig
Peppercorn, Amanda
Alexander, Elizabeth
Pang, Phillip S.
Free, Almena
Brinson, Cynthia
Aldinger, Melissa
Shapiro, Adrienne E.
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (21): : 1941 - 1950
[40] SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence
Dao, Thi Loi
Hoang, Van Thuan
Colson, Philippe
Lagier, Jean Christophe
Million, Matthieu
Raoult, Didier
Levasseur, Anthony
Gautret, Philippe
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (12)

← 1 2 3 4 5 →